Monopar Therapeutics (MNPR) Times Interest Earned (2022)
Monopar Therapeutics' (MNPR) quarterly Times Interest Earned came in at -$0.26 in Q4 2022.
Monopar Therapeutics (MNPR) Times Interest Earned (2022) Analysis & Trends
Monopar Therapeutics has disclosed Times Interest Earned across 1 years of filings, most recently posting -$0.26 for Q4 2022.
- Times Interest Earned for Q4 2022 came in at -$0.26, changed N/A year-over-year; the trailing twelve-month figure through Dec 2022 was -$0.95 (changed N/A YoY), and the FY2023 annual result was $0.37, up 138.93% from the prior year.
- Times Interest Earned came in at -$0.26 for Q4 2022 at Monopar Therapeutics.
- In the past five years, Times Interest Earned ranged from a high of -$0.26 in Q4 2022 to a low of -$0.26 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -258.33 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 11.79 |
| 10 | Monopar Therapeutics | 441.25 Mn | 441.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -0.26 |